The risk of developing liver cancer is increased in people who have cirrhosis, a disease in which healthy liver tissue is ...
Have you or someone you know recently been diagnosed with colon cancer? If so, we're talking about the treatments and approaches for those diagnosed at Moffitt Cancer Center.
Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.
11h
FOX 26 Houston on MSNBreast cancer treatment advancements emerge from Baylor College of MedicineBaylor College of Medicine in Houston is at the forefront of advancements in breast cancer treatment by pioneering a "right-sizing surgery", potentially eliminating the need for surgery, chemotherapy, ...
Medicant Hospital, in collaboration with the Bokaro Obstetrics and Gynaecological Society (BOGS), organized a Continuing Medical Education (CME) program on Sunday, focusing on cervical and ovarian ...
Baird Medical Investment Holdings Ltd. ("Baird Medical" or the "Company"), a leader in microwave ablation (MWA) technology, remains committed to advancing physician education and recently supported Dr ...
(IN BRIEF) Amadix, a Spanish biotech company focused on non-invasive blood tests for early cancer detection, has secured a €15 million loan from the European Investment Bank (EIB). This funding, ...
An avid golfer who dismissed signs of cancer as a mark from his golf bag has become the first patient in the UK to have ...
What happens when the biodiversity witnessed by one generation fades into memory the next? These questions are crossroads at ...
18h
Ivanhoe on MSNBattling Bladder Cancer: New Gene Therapy to The RescueA breakthrough in bladder cancer treatment is helping to save more lives. The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year, with almost 17,000 ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...
MTX110 is a solubilized formulation of the histone deacetylase (HDAC) inhibitor, panobinostat. This proprietary formulation enables delivery of the product via convection-enhanced delivery (CED) at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results